| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/10/1999 | EP0900787A1 Process for preparing pyrrolidine derivatives |
| 03/10/1999 | EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 03/10/1999 | EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 03/10/1999 | CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation |
| 03/10/1999 | CN1209994A Use of inhibitors of sodium-hyfrogen exchanger for production of pharmaceutical for treatment of disorders which are caused by protozoa |
| 03/09/1999 | US5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use |
| 03/09/1999 | US5880136 Sulfonamide fibrinogen receptor antagonists |
| 03/04/1999 | WO1999010313A1 N-aroylphenylalanine derivatives |
| 03/04/1999 | WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/04/1999 | WO1999009975A1 4-cyano-4-deformylsordaricin derivatives |
| 03/04/1999 | CA2300121A1 N-alkanoylphenylalanine derivatives |
| 03/04/1999 | CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/03/1999 | EP0898963A2 Congestive heart failure treatment |
| 03/03/1999 | EP0898569A1 Piperidines and pyrrolidines |
| 03/03/1999 | EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | EP0707576B1 Substituted aryl-keto-enolic heterocycles |
| 03/03/1999 | EP0674641B1 Pyrrolopyrimidines as crf antagonists |
| 03/03/1999 | CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor |
| 03/03/1999 | CN1042328C Substituted cyclohexane derivative and medicine containing same |
| 03/02/1999 | US5877327 Anti-fatigue coagents for rubber vulcanization |
| 03/02/1999 | US5877325 Quaternary ammonium compounds as bleach activators and their preparation |
| 03/02/1999 | US5877297 Boronic compound complexing reagents and highly stable complexes |
| 03/02/1999 | US5877204 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions |
| 03/02/1999 | US5877196 N- 4-(imidazolyl or pyrazolyl)phenyl(oxy, sulfinyl, sulfenyl or sulfonyl)alkyl!carboxamides, sulfonamides or phosphoramides having antiarrhythmic properties |
| 03/02/1999 | US5876464 Aqueous solution |
| 02/28/1999 | CA2246407A1 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
| 02/25/1999 | WO1999009041A2 Solution phase synthesis of oligonucleotides |
| 02/25/1999 | WO1999009006A1 SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF |
| 02/25/1999 | WO1999008697A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues |
| 02/25/1999 | CA2301054A1 Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof |
| 02/25/1999 | CA2300874A1 Solution phase synthesis of oligonucleotides |
| 02/25/1999 | CA2300848A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/23/1999 | US5874549 Acid-cleavable compound |
| 02/23/1999 | US5874532 Method for solution phase synthesis of oligonucleotides and peptides |
| 02/23/1999 | US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| 02/23/1999 | US5874467 Phenylacetic acid derivatives and use as fungicides |
| 02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
| 02/23/1999 | US5874449 Inhibitors of immunophilin |
| 02/23/1999 | US5874437 Impotence |
| 02/23/1999 | US5874435 Psychological disorders; analgesics |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/23/1999 | CA2168265C Antidepressant |
| 02/23/1999 | CA2166061C Novel processes for preparing (s)-4-amino-hepta-5,6-dienoic acid and intermediates thereof |
| 02/23/1999 | CA1340404C Process for preparing (+) -1,2-dihydro-3h-pyrrolo (1, 2-a) pyrrole-1,7-dicarboxylates |
| 02/18/1999 | WO1999007706A1 Quinolone carboxylic acid derivatives |
| 02/18/1999 | WO1999007688A1 2-benzoyl-cyclohexane-1,3-diones |
| 02/18/1999 | WO1999007672A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 02/18/1999 | WO1999007377A1 1-[4-(substituted alkoxy)benzyl]naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | WO1999007363A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 02/18/1999 | CA2298651A1 1-¬4-(substituted alkoxy)benzyl|naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | CA2298574A1 2-benzoyl-cyclohexane-1,3-diones |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/17/1999 | CN1208409A Novel benzoyl guanidine derivatives process for their preparation and their use in the preparation of medicines |
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/17/1999 | CN1208347A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/16/1999 | US5872261 Multistage process with esterification and reaction with hydroxylamine |
| 02/16/1999 | US5872224 Boronic compound complexing reagents and highly stable complexes |
| 02/16/1999 | US5872191 Reacting a polyoxyalkylene compound having carboxylic group at the end with n-hydroxysuccinimide in an inert solvent to obatain a reaction product, dissolving the product in chloroform, crystalllizing by adding aliphatic hydrocarbons |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872117 Treating cerebrovascular dementia, senile dementia, alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy |
| 02/16/1999 | US5872115 Compounds for treatment of hypercholesterolemia, ischemic heart disease, cerebrovascular disease or atherosclerosis |
| 02/16/1999 | CA2079617C Recovery of aprotic polar solvents from their saline aqueous solutions |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006351A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1998050325A3 Building blocks derived from 1,2-aminoalcohols |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298595A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/10/1999 | EP0895990A1 Method for the preparation of 1-pyruvyl-L-proline |
| 02/10/1999 | EP0895989A1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity |
| 02/10/1999 | EP0756546B1 Dye diffusion thermal transfer printing |
| 02/10/1999 | CN1207390A Five-membered aromatic heterocyclic compounds contg. beta-position trifluoromethyl group and synthesis thereof |
| 02/10/1999 | CN1207388A Process for producing 1-aminopyrrolidine, and 1-aminopyrrolidine according to the process |
| 02/09/1999 | US5869725 Derivatives of aminosulfonic acids, utilization of the same in the synthesis of pseudopeptides and process for their preparation |
| 02/09/1999 | US5869698 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules |
| 02/09/1999 | US5869695 Process for making derivatized polymers of maleic anhydride containing maleamic acid and its corresponding cyclic imide repeat units |
| 02/09/1999 | US5869694 Process for preparing 4-hydroxy-2-pyrrolidone |
| 02/09/1999 | US5869675 Lactacystin derivatives |
| 02/09/1999 | US5869671 Reacting phosphorus pentachloride with amino acid, coupling product with silylated amino acid in nonaqueous solvent to form peptide |
| 02/09/1999 | US5869623 Boronic compound complexing reagents and complexes |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | CA1340387C Heterobifunctional coupling agents |
| 02/06/1999 | CA2244536A1 Process for preparing 1-pyruvyl-l-proline |
| 02/04/1999 | WO1999005096A2 Urokinase inhibitors |
| 02/04/1999 | WO1999005095A1 Aminocycloalkane compounds |
| 02/04/1999 | WO1999005091A1 Novel compound having effect of promoting neuron differentiation |
| 02/04/1999 | WO1999004778A1 Pharmaceutical compounds |
| 02/04/1999 | CA2297943A1 Novel compound having effect of promoting neuron differentiation |